Company Filing History:
Years Active: 2008
Title: Innovations of Sung-Oh Huh in Therapeutic Applications
Introduction
Sung-Oh Huh is a notable inventor based in Kangwon-do, South Korea. He has made significant contributions to the field of therapeutics, particularly through his innovative work on the G2A receptor. His research focuses on addressing diseases associated with neutrophil accumulation and hyperactivity.
Latest Patents
Sung-Oh Huh holds a patent for the therapeutic use of agonist ligands specific to the G2A receptor. This invention relates to methods for treating diseases or disorders linked to neutrophil accumulation, excessive release of IL-8, and microbial infections. The patent outlines the administration of LPC (lysophosphatidylcholine), SPC (sphingophosphorylcholine), or their derivatives to effectively treat inflammatory diseases and ischemia-reperfusion injuries.
Career Highlights
Throughout his career, Sung-Oh Huh has worked with various companies, including Biosynergen, Inc. and Arimed Inc. His experience in these organizations has contributed to his expertise in therapeutic innovations.
Collaborations
Sung-Oh Huh has collaborated with notable colleagues such as Yung-Hi Kim and Dong-Keun Song. These partnerships have further enhanced his research and development efforts in the field of therapeutics.
Conclusion
Sung-Oh Huh's innovative work on the G2A receptor and his contributions to therapeutic applications highlight his importance in the field of medical research. His patent and collaborations reflect a commitment to advancing treatment options for various diseases.